The ROE as of December 2024 (TTM) for Nurix Therapeutics, Inc. (NRIX) is -63.39%

According to Nurix Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -63.39%. This represents a change of 259.45% compared to the average of -17.63% of the last 4 quarters.

Nurix Therapeutics, Inc. (NRIX) Historical ROE (quarterly & annually)

How has NRIX ROE performed in the past?

The mean historical ROE of Nurix Therapeutics, Inc. over the last ten years is -18.74%. The current -63.39% ROE has changed 238.30% with respect to the historical average. Over the past ten years (40 quarters), NRIX's ROE was at its highest in in the February 2020 quarter at 57.35%. The ROE was at its lowest in in the February 2024 quarter at -24.60%.

Nurix Therapeutics, Inc. (NRIX) ROE by Quarter and Year

Discovering the peaks and valleys of Nurix Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nurix Therapeutics, Inc. (NRIX) Average ROE

How has NRIX ROE performed in the past?

The current ROE of Nurix Therapeutics, Inc. (NRIX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Nurix Therapeutics, Inc. (NRIX) ROE vs. Peers

How is NRIX’s ROE compared to its peers?

Nurix Therapeutics, Inc.’s ROE is less than Foghorn Therapeutics Inc. (167.93%), greater than Shattuck Labs, Inc. (-61.92%), greater than Monte Rosa Therapeutics, Inc. (-62.68%), greater than Kymera Therapeutics, Inc. (-24.96%), greater than C4 Therapeutics, Inc. (-42.45%), greater than Arvinas, Inc. (-50.26%), less than Eliem Therapeutics, Inc. (0%), greater than Prelude Therapeutics Incorporated (-66.88%), greater than Relay Therapeutics, Inc. (-45.75%), greater than Stoke Therapeutics, Inc. (-54.45%), greater than Pliant Therapeutics, Inc. (-48.91%), greater than Black Diamond Therapeutics, Inc. (-68.08%), greater than Nkarta, Inc. (-27.13%), greater than Lyell Immunopharma, Inc. (-34.64%), greater than Generation Bio Co. (-104.85%), greater than Sana Biotechnology, Inc. (-94.47%),

Build a custom stock screener for Nurix Therapeutics, Inc. (NRIX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nurix Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nurix Therapeutics, Inc. (NRIX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nurix Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.